CS-TATI-1

N/A

Report date: 2025/01/26 17:08:07
NME

Base Information

Drug NameCS-TATI-1
Drug Alias Namephytocannabinoid-based therapeutics (Cannabis Science)phytocannabinoid-based therapeutics (Cannabis Science)CS-TATI-1
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitorsCannabinoid receptor agonists
TargetsCannabinoid receptorHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsWounds and InjuriesSkin DiseasesArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCannabis Science
China Registration ClassN/A

Develop Information

Active CompaniesCannabis Science
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesSkin DiseasesArthritis, Rheumatoid +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A